A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult Participants
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 373 participants.
Also called NCT05618808
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 373 participants
- Sponsor
- Registry
-
NCT05618808
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Belgium, Bulgaria, Canada, Hungary, Latvia, Lithuania, Poland
- Registry status
- Completed
Technical summary
Registry record NCT05618808. Randomized; no masking; primary purpose treatment. Start 2023-05-24 (actual); primary completion 2024-05-27 (actual). Results posted on 2025-07-16.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult Participants
- Condition
- Venous Thromboembolism
- Intervention (Drug)
- REGN9933
- Intervention (Drug)
- Enoxaparin
- Intervention (Drug)
- Apixiban
- Lead sponsor
- Regeneron Pharmaceuticals
Record details
- Record id
cardio:ct-nct05618808- Content hash
ad16755f2debb9efd5c6edd4c3a840e1956bc16ddd35ca2a902ad5240aa9f83d